In addition, the CHMP recommended new contraindications and strengthened warnings for piroxicam, further details of which are proided in a separate question-and-answer document.

• 此外，CHMP还建议了吡罗昔康新的禁忌症并强调了警告信息，其详细内容参见有关吡罗昔康评价情况问答的单独文件。